Northern Trust Corp Mirum Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 367,485 shares of MIRM stock, worth $15.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

367,485

Previous 277,366 32.49%

Holding current value

$15.6 Million

Previous $9.48 Million 51.12%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$33.68 - $44.74 $3.04 Million - $4.03 Million	90,119 Added 32.49%	367,485 $14.3 Million
Q2 2024 Aug 14, 2024	SELL	$23.57 - $34.85 $87,515 - $129,398	-3,713 Reduced 1.32%	277,366 $9.48 Million
Q1 2024 May 14, 2024	SELL	$24.92 - $30.02 $173,343 - $208,819	-6,956 Reduced 2.41%	281,079 $7.06 Million
Q4 2023 Feb 13, 2024	BUY	$27.14 - $34.93 $347,419 - $447,138	12,801 Added 4.65%	288,035 $8.5 Million
Q3 2023 Nov 13, 2023	BUY	$24.63 - $32.85 $33,866 - $45,168	1,375 Added 0.5%	275,234 $8.7 Million
Q2 2023 Aug 11, 2023	BUY	$23.51 - $30.09 $1.4 Million - $1.8 Million	59,662 Added 27.85%	273,859 $7.08 Million
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $29,015 - $36,439	1,512 Added 0.71%	214,197 $5.15 Million
Q4 2022 Feb 13, 2023	BUY	$17.59 - $23.83 $79,559 - $107,783	4,523 Added 2.17%	212,685 $4.15 Million
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $627,292 - $924,298	31,396 Added 17.76%	208,162 $4.37 Million
Q2 2022 Aug 12, 2022	BUY	$18.42 - $27.5 $1.67 Million - $2.49 Million	90,439 Added 104.76%	176,766 $3.44 Million
Q1 2022 May 13, 2022	SELL	$15.5 - $23.93 $45,074 - $69,588	-2,908 Reduced 3.26%	86,327 $1.9 Million
Q4 2021 Feb 08, 2022	BUY	$13.05 - $19.35 $6,394 - $9,481	490 Added 0.55%	89,235 $1.42 Million
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $100,900 - $145,961	-7,233 Reduced 7.54%	88,745 $1.77 Million
Q2 2021 Aug 13, 2021	SELL	$15.84 - $20.6 $15,158 - $19,714	-957 Reduced 0.99%	95,978 $1.66 Million
Q1 2021 May 12, 2021	SELL	$16.29 - $21.92 $22,789 - $30,666	-1,399 Reduced 1.42%	96,935 $1.92 Million
Q4 2020 Feb 11, 2021	SELL	$15.75 - $25.45 $41,816 - $67,569	-2,655 Reduced 2.63%	98,334 $1.72 Million
Q3 2020 Nov 16, 2020	BUY	$18.4 - $26.59 $11,684 - $16,884	635 Added 0.63%	100,989 $1.95 Million
Q2 2020 Aug 14, 2020	BUY	$11.51 - $20.97 $350,456 - $638,494	30,448 Added 43.56%	100,354 $1.95 Million
Q1 2020 May 14, 2020	BUY	$9.38 - $23.79 $218,497 - $554,164	23,294 Added 49.97%	69,906 $978,000
Q4 2019 Feb 14, 2020	BUY	$6.84 - $25.9 $67,025 - $253,794	9,799 Added 26.62%	46,612 $1.14 Million
Q3 2019 Nov 13, 2019	BUY	$9.16 - $14.77 $337,207 - $543,728	36,813 New	36,813 $370,000

Others Institutions Holding MIRM

# of Institutions

190

Shares Held

54M

Call Options Held

177K

Put Options Held

167K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.56B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Mirum Pharmaceuticals, Inc. Transaction History